Yossi Maimon

Inga fler pågående positioner

55 år

Health Technology

Consumer Services

Profil

Yossi Maimon formerly worked at ColBar LifeScience Ltd., as Chief Financial Officer from 2002 to 2006, Protalix Biotherapeutics, Inc., as CFO, Secretary, Treasurer & Vice President from 2012 to 2019, Protalix Ltd., as Chief Financial Officer, and Old Ayala, Inc., as Chief Financial Officer, Secretary & Treasurer.
Mr. Maimon received his undergraduate degree from City University of New York and Masters Business Admin degree from Tel-Aviv University.

Tidigare kända positioner av Yossi Maimon

Företag	Position	Slut
ADVAXIS, INC.	Finansdirektör/CFO	2023-01-19
PROTALIX BIOTHERAPEUTICS, INC.	Finansdirektör/CFO	2019-07-22
ColBar LifeScience Ltd. ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology Develops technology for tissue regeneration and tissue engineering	Finansdirektör/CFO	2006-01-01
Protalix Ltd.	Finansdirektör/CFO	-

Se detaljerna i Yossi Maimons erfarenhet

Yossi Maimons utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Yossi Maimons erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	6
City University of New York City University of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tel-Aviv University Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ColBar LifeScience Ltd. ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology Develops technology for tissue regeneration and tissue engineering	Health Technology
Protalix Biotherapeutics, Inc. Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins	Health Technology
Protalix Ltd.
Old Ayala, Inc. Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company which develops cancer therapies	Health Technology